Cargando…
Lentigo Maligna on a Difficult Location of the Face Treated with 5% Imiquimod: A Case Report of 2-Year Follow-Up
Topical imiquimod is an off-label alternative treatment for lentigo maligna used when surgery cannot be performed. Severe inflammatory response induced by this drug may generate many complaints and force patients to discontinue use. We present a case in which interval treatment with 5% topical imiqu...
Autores principales: | Misiak-Galazka, Magdalena, Czuwara, Joanna, Galazka, Adam, Czaplicka, Anna, Rudnicka, Lidia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850510/ https://www.ncbi.nlm.nih.gov/pubmed/35083713 http://dx.doi.org/10.1007/s13555-021-00667-w |
Ejemplares similares
-
The Accuracy of Clinical Diagnosis in 2135 Lesions on the Face. A Retrospective Analysis of Histopathological Records
por: Czaplicka, Anna, et al.
Publicado: (2022) -
Topical Imiquimod Treatment of Lentigo Maligna
por: Ventura, F., et al.
Publicado: (2009) -
Observational Study of Topical Imiquimod Immunotherapy in the Treatment of Difficult Lentigo Maligna
por: Craythorne, E.E., et al.
Publicado: (2008) -
Long-Term Follow-Up of Lentigo Maligna Patients Treated with Imiquimod 5% Cream
por: Seyed Jafari, S. Morteza, et al.
Publicado: (2023) -
Topical Treatment of Melanoma In Situ, Lentigo Maligna, and Lentigo Maligna Melanoma with Imiquimod Cream: A Systematic Review of the Literature
por: Vaienti, Silvia, et al.
Publicado: (2023)